Breast Cancer (Clinical Trials)

Trial Aims to Improve Survival/Quality of Life for Women with Cancer

Published in Cancer Weekly, June 17th, 1996

Improving treatment for women with breast cancer is the focus of a clinical trial recently announced and jointly sponsored by the U.S. National Cancer Institute of Canada and Sandoz Canada Inc., Toronto, Ontario, Canada.

The trial will be looking at post-operative adjuvant (supplementary) treatment of breast cancer. Approximately 800 Canadian women will be recruited to the trial, which has been scheduled to begin in summer 1996.

In a randomized fashion, the women receive either the drug tamoxifen by itself, or a combination of tamoxifen and an agent called octreotide. The women will be followed for seven years to ascertain if there is improved...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-06-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry